CIK: 0001600175
Total reported value
$55.3M
Reporting period: 2019-09-30 · Number of holdings: 55
Opus Point Partners Management, LLC disclosed 55 holdings in its latest 13F filing for the period ending 2019-09-30, with total reported value of $55.3M and a quarterly turnover rate of 27.3%.
Browse other institutions with under $100M AUMBrowse other institutions starting with "O"
Opus Point Partners Management, LLC's disclosed holdings carry a Herfindahl concentration index of 0.155 — mathematically equivalent to about 6 equally-sized positions, well below its 55 actual disclosed holdings. That gap points to a strategy built around a small core of high-conviction bets rather than broad diversification.
Position sizes vary widely across the portfolio (a coefficient of variation of 2.74), with a handful of outsized bets alongside many smaller positions.
No strong tilt toward either adding to existing winners or initiating outsized new positions was observed in the latest reported quarter.
Sector classification currently covers about 10% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Add IBB
0.0% -$2.0M
Trim LABUUSD
+1.4% -$1.9M
Add 34960Q109
+162.2% $514.0K
Add SGENEUR
+0.7% $300.0K
Add BMY
0.0% $176.0K
Trim QURE
0.0% -$551.0K
Showing top 54 holdings (of 55 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | IBB | Ishares Biotechnology ETF | ETF-Tech | 37.76% | +3.86% | — | |
| 2 | LABUUSD | Drx Dly S&p Biotech Bull 3x | ETF-Tech | 5.58% | -1.73% | +1.45% | |
| 3 | MTD | Mettler-toledo International | Stock-Healthcare | 4.12% | +0.10% | — | |
| 4 | BMY | Bristol-myers Squibb Co | Stock-Healthcare | 3.02% | +0.81% | — | |
| 5 | SGENEUR | Seagen INC | Stock-Other | 2.78% | +0.95% | +0.66% | |
| 6 | ILMN | Illumina INC | Stock-Healthcare | 2.59% | +0.04% | +0.47% | |
| 7 | VRTX | Vertex Pharmaceuticals INC | Stock-Healthcare | 2.54% | +0.32% | +1.05% | |
| 8 | IONS | Ionis Pharmaceuticals INC | Stock-Healthcare | 2.18% | +0.27% | — | |
| 9 | ALNY | Alnylam Pharmaceuticals INC | Stock-Healthcare | 1.99% | +0.56% | +2.49% | |
| 10 | ALXN | Alexion Pharmaceuticals INC | Stock-Other | 1.76% | -0.16% | +0.06% | |
| 11 | QGEN | Qiagen N.V. | Stock-Healthcare | 1.72% | -0.01% | — | |
| 12 | ONCEEUR | Spark Therapeutics INC | Stock-Other | 1.70% | +0.23% | — | |
| 13 | ✓ | Stock-Other | 1.56% | +1.04% | +162.17% | ||
| 14 | ✓ | Proqr Thrapeutics N V | Stock-Other | 1.44% | -0.42% | — | |
| 15 | INCY | Incyte CORP | Stock-Healthcare | 1.43% | +0.10% | +0.43% | |
| 16 | EXK | Exact Sciences CORP | Stock-Materials | 1.39% | -0.10% | — | |
| 17 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 1.22% | — | +9.82% | |
| 18 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 1.18% | -0.01% | +3.19% | |
| 19 | DCPHEUR | Deciphera Pharmaceuticals In | Stock-Other | 1.14% | +0.52% | — | |
| 20 | ASND | Ascendis Pharma A/S | Stock-Other | 1.08% | +0.03% | — | |
| 21 | QURE | uniQure N.V. | Stock-Other | 1.01% | -0.63% | — | |
| 22 | CELG | Celgene CORP | Stock-Other | 1.01% | +0.24% | — | |
| 23 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 0.98% | +0.06% | — | |
| 24 | EPZMEUR | Epizyme INC | Stock-Other | 0.94% | — | — | |
| 25 | ✓ | Amarin Corp PLC | Stock-Other | 0.92% | +0.44% | +102.16% | |
| 26 | 2655787D | Blueprint Medicines CORP | Stock-Other | 0.90% | -0.05% | — | |
| 27 | BOLDEUR | Audentes Therapeutics INC | Stock-Other | 0.88% | -0.09% | — | |
| 28 | GTHXEUR | G1 Therapeutics INC | Stock-Other | 0.86% | -0.09% | — | |
| 29 | GBTUSD | Global Blood Therapeutics In | Stock-Other | 0.83% | +0.09% | — | |
| 30 | BHVN | Biohaven Ltd. | Stock-Other | 0.82% | — | — | |
| 31 | ARNAEUR | Arena Pharmaceuticals INC | Stock-Other | 0.81% | -0.04% | — | |
| 32 | ACAD | Acadia Pharmaceuticals INC | Stock-Healthcare | 0.78% | +0.31% | +0.20% | |
| 33 | GWPH | Gw Pharmaceuticals LTD | Stock-Other | 0.76% | -0.18% | — | |
| 34 | ZGNXEUR | Zogenix INC | Stock-Other | 0.70% | +0.01% | — | |
| 35 | MGNX | Macrogenics INC | Stock-Other | 0.69% | -0.06% | — | |
| 36 | NTLA | Intellia Therapeutics INC | Stock-Other | 0.69% | — | — | |
| 37 | TECH | Bio-techne CORP | Stock-Healthcare | 0.55% | — | — | |
| 38 | IQV | Iqvia Holdings INC | Stock-Healthcare | 0.54% | — | — | |
| 39 | AMGN | Amgen INC | Stock-Healthcare | 0.53% | — | +8.66% | |
| 40 | NBIX | Neurocrine Biosciences INC | Stock-Healthcare | 0.51% | — | +3.82% | |
| 41 | CKPTUSD | Checkpoint Therapeutics INC | Stock-Other | 0.51% | — | — | |
| 42 | CRL | Charles River Laboratories | Stock-Healthcare | 0.51% | — | — | |
| 43 | UTHR | United Therapeutics CORP | Stock-Healthcare | 0.50% | +0.50% | NEW | |
| 44 | GRFS | Grifols Sa-adr | Stock-Other | 0.48% | — | — | |
| 45 | BIIB | Biogen INC | Stock-Healthcare | 0.47% | — | — | |
| 46 | ICPTUSD | Intercept Pharmaceuticals In | Stock-Other | 0.47% | -0.22% | -33.14% | |
| 47 | GILD | Gilead Sciences INC | Stock-Healthcare | 0.47% | — | — | |
| 48 | LGND | Ligand Pharmaceuticals | Stock-Healthcare | 0.44% | — | +15.02% | |
| 49 | NKTREUR | Nektar Therapeutics | Stock-Other | 0.42% | -0.24% | +3.39% | |
| 50 | EXEL | Exelixis INC | Stock-Healthcare | 0.42% | — | +14.79% |
Not enough priced holdings yet to compute performance
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2019-09-30 | 55 | $55.3M | 27 | |
| 2019-06-30 | 63 | $67.6M | 18 | |
| 2019-03-31 | 75 | $73.8M | 55 | |
| 2018-12-31 | 40 | $45.4M | 96 | |
| 2018-09-30 | 47 | $41.9M | 62 | |
| 2018-06-30 | 50 | $46.1M | 45 | |
| 2018-03-31 | 51 | $51.0M | 98 | |
| 2017-12-31 | 65 | $115.6M | 31 | |
| 2017-09-30 | 63 | $111.5M | 100 | |
| 2017-06-30 | 66 | $108.6M | 0 | |
| 2017-03-31 | 67 | $134.7M | 39 | |
| 2016-12-31 | 57 | $125.5M | 49 | |
| 2016-09-30 | 50 | $178.3M | 61 | |
| 2016-06-30 | 43 | $103.5M | 48 | |
| 2016-03-31 | 52 | $129.4M | 65 | |
| 2015-12-31 | 57 | $151.4M | 83 | |
| 2015-09-30 | 56 | $181.1M | 70 | |
| 2015-06-30 | 57 | $126.3M | 36 | |
| 2015-03-31 | 65 | $119.3M | 44 | |
| 2014-12-31 | 60 | $101.1M | 0 |
Opus Point Partners Management, LLC's most significant position changes for 2019-09-30: Sold out: Immunomedics INC (IMMU); Sold out: Sarepta Therapeutics INC (SRPT); Sold out: ; Sold out: Insmed INC (INSM); Sold out: Pacira Biosciences INC (PCRX).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | IBB | Ishares Biotechnology ETF | +3.9% | — | Unchanged |
| 2 | ✓ | +1% | +162.17% | Add | |
| 3 | SGENEUR | Seagen INC | +1% | +0.66% | Add |
| 4 | BMY | Bristol-myers Squibb Co | +0.8% | — | Unchanged |
| 5 | ALNY | Alnylam Pharmaceuticals INC | +0.6% | +2.49% | Add |
| 6 | DCPHEUR | Deciphera Pharmaceuticals In | +0.5% | — | Unchanged |
| 7 | ✓ | Amarin Corp PLC | +0.4% | +102.16% | Add |
| 8 | VRTX | Vertex Pharmaceuticals INC | +0.3% | +1.05% | Add |
| 9 | ACAD | Acadia Pharmaceuticals INC | +0.3% | +0.20% | Add |
| 10 | IONS | Ionis Pharmaceuticals INC | +0.3% | — | Unchanged |
| 11 | CELG | Celgene CORP | +0.2% | — | Unchanged |
| 12 | ONCEEUR | Spark Therapeutics INC | +0.2% | — | Unchanged |
| 13 | MTD | Mettler-toledo International | +0.1% | — | Unchanged |
| 14 | INCY | Incyte CORP | +0.1% | +0.43% | Add |
| 15 | GBTUSD | Global Blood Therapeutics In | +0.1% | — | Unchanged |
| 16 | CRSP | CRISPR Therapeutics AG | +0.1% | — | Unchanged |
| 17 | ILMN | Illumina INC | 0% | +0.47% | Add |
| 18 | ASND | Ascendis Pharma A/S | 0% | — | Unchanged |
| 19 | ZGNXEUR | Zogenix INC | 0% | — | Unchanged |
| 20 | EPZMEUR | Epizyme INC | — | — | Unchanged |
| 21 | NTLA | Intellia Therapeutics INC | — | — | Unchanged |
| 22 | CKPTUSD | Checkpoint Therapeutics INC | — | — | Unchanged |
| 23 | QGEN | Qiagen N.V. | 0% | — | Unchanged |
| 24 | BMRN | Biomarin Pharmaceutical INC | 0% | +3.19% | Add |
| 25 | ARNAEUR | Arena Pharmaceuticals INC | 0% | — | Unchanged |
| 26 | 2655787D | Blueprint Medicines CORP | -0.1% | — | Unchanged |
| 27 | MGNX | Macrogenics INC | -0.1% | — | Unchanged |
| 28 | BOLDEUR | Audentes Therapeutics INC | -0.1% | — | Unchanged |
| 29 | GTHXEUR | G1 Therapeutics INC | -0.1% | — | Unchanged |
| 30 | RARE | Ultragenyx Pharmaceutical In | -0.1% | — | Unchanged |
| 31 | EXK | Exact Sciences CORP | -0.1% | — | Unchanged |
| 32 | ALXN | Alexion Pharmaceuticals INC | -0.2% | +0.06% | Add |
| 33 | GWPH | Gw Pharmaceuticals LTD | -0.2% | — | Unchanged |
| 34 | ICPTUSD | Intercept Pharmaceuticals In | -0.2% | -33.14% | Trim |
| 35 | NKTREUR | Nektar Therapeutics | -0.2% | +3.39% | Add |
| 36 | ✓ | Proqr Thrapeutics N V | -0.4% | — | Unchanged |
| 37 | QURE | uniQure N.V. | -0.6% | — | Unchanged |
| 38 | LABUUSD | Drx Dly S&p Biotech Bull 3x | -1.7% | +1.45% | Add |
| 39 | IMMU | Immunomedics INC | — | EXIT | Sold out |
| 40 | SRPT | Sarepta Therapeutics INC | — | EXIT | Sold out |
| 41 | ✓ | — | EXIT | Sold out | |
| 42 | INSM | Insmed INC | — | EXIT | Sold out |
| 43 | PCRX | Pacira Biosciences INC | — | EXIT | Sold out |
| 44 | AM6 | Amicus Therapeutics INC | — | EXIT | Sold out |
| 45 | VKTX | Viking Therapeutics INC | — | EXIT | Sold out |
| 46 | MDGL | Madrigal Pharmaceuticals INC | — | EXIT | Sold out |
| 47 | ANAB | Anaptysbio INC | — | EXIT | Sold out |
| 48 | UTHR | United Therapeutics CORP | — | NEW | New buy |
| 49 | AGIO | Agios Pharmaceuticals INC | — | EXIT | Sold out |
| 50 | ALKS | Alkermes plc | — | NEW | New buy |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2019-09-30 | 2019-11-14 | 13F-HR | View on EDGAR |
| 2019-06-30 | 2019-08-14 | 13F-HR | View on EDGAR |
| 2019-03-31 | 2019-05-15 | 13F-HR | View on EDGAR |
| 2018-12-31 | 2019-02-14 | 13F-HR | View on EDGAR |
| 2018-09-30 | 2018-11-14 | 13F-HR | View on EDGAR |
| 2018-06-30 | 2018-08-14 | 13F-HR | View on EDGAR |
| 2018-03-31 | 2018-05-15 | 13F-HR | View on EDGAR |
| 2017-12-31 | 2018-02-14 | 13F-HR | View on EDGAR |
| 2017-09-30 | 2017-11-14 | 13F-HR | View on EDGAR |
| 2017-06-30 | 2017-11-17 | Amendment | View on EDGAR |
| 2017-06-30 | 2017-08-14 | 13F-HR | View on EDGAR |
| 2017-03-31 | 2017-05-15 | 13F-HR | View on EDGAR |
| 2016-12-31 | 2017-02-14 | 13F-HR | View on EDGAR |
| 2016-09-30 | 2016-11-14 | 13F-HR | View on EDGAR |
| 2016-06-30 | 2016-08-15 | 13F-HR | View on EDGAR |
| 2016-03-31 | 2016-05-16 | Amendment | View on EDGAR |
| 2016-03-31 | 2016-05-13 | 13F-HR | View on EDGAR |
| 2015-12-31 | 2016-02-16 | 13F-HR | View on EDGAR |
| 2015-09-30 | 2015-11-16 | 13F-HR | View on EDGAR |
| 2015-06-30 | 2015-08-14 | 13F-HR | View on EDGAR |
| 2015-03-31 | 2015-05-18 | 13F-HR | View on EDGAR |
| 2014-12-31 | 2015-02-17 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001289851
Total reported value
$55.4M
18 stks
2017-12-31
Stale — no recent filing
AUM within 0.0% of this institution
CIK 0001389848
Total reported value
$55.4M
64 stks
2026-06-30
AUM within 0.0% of this institution
CIK 0001814601
Total reported value
$55.4M
1 stks
2023-09-30
Stale — no recent filing
AUM within 0.1% of this institution
Institutions with overlapping top holdings
CIK 0000763848
Total reported value
$2.2B
152 stks
2020-09-30
Stale — no recent filing
1 of the top 5 holdings overlap, including Bristol-myers Squibb Co
CIK 0000779519
Total reported value
$58.9M
41 stks
2022-12-31
Stale — no recent filing
1 of the top 5 holdings overlap, including Ishares Biotechnology ETF
CIK 0000833018
Total reported value
$5.6B
202 stks
2015-12-31
Stale — no recent filing
1 of the top 5 holdings overlap, including Bristol-myers Squibb Co